The Board and CEO of Emotra AB herewith present the year-end report for the financial year 2017. 180223- Year-end report 2017
The board of Emotra AB (“Emotra”) hereby announces that they have carried out a review of the first six EDOR® training seminars and found that they have not been sufficiently cost-effective. Our chosen approach has turned out to be more expensive than anticipated and has not yet produced the expected results. In 2018 we will [...]
The Board of Directors and the CEO of Emotra AB (publ) hereby present the interim report for the first nine months of 2017. 171024- Interim report Jan-Sept 2017
As we have previously stated, Emotra AB (“Emotra”) intends to carry out 12 seminars in various countries in 2017 to train new clinics on the use of EDOR. Our earlier sessions were held in Romania, France, Kazakhstan and Portugal, while this latest session was held in Hungary. Yesterday, October 3, 2017, we held yet another [...]
The Board and CEO of Emotra AB (publ) hereby present the interim report for the first six months of 2017. 170823- Interim report Jan-June 2017_EN
Emotra AB (“Emotra”) has previously announced that the Company, as a first step in the build-up of its international marketing organisation, is recruiting a Marketing Manager. Emotra is pleased to announce that we have now employed Daniel Poté as our Marketing Manager. Mr Poté comes to us from the position as Global Product Manager at [...]
Emotra AB (“Emotra”) carried out a rights issue of shares in June, 2017. This new share issue, encompassing 4,184,399 shares, was also open to the general public. The last day for trading in PSS (Paid Subscribed Shares) is July 20, 2017 and the stop date is July 24, 2017. 170718 - Emotra - Final [...]
Emotra AB (“Emotra”) has already announced the Company’s plans to train new clinics on how to use EDOR®. The announcement disclosed the Company’s plans to carry out a total of 12 training sessions in various European countries in 2017, with two of these before the summer. Emotra is proud to announce that the second of [...]
The Annual General Meeting of EMOTRA AB (publ) was held on Friday, June 30, 2017. The resolutions, summarised below, were adopted with the necessary majority. 170703 - Emotra - Communiqué from AGM
As a result of the recent rights issue in Emotra AB (publ) (“Emotra”), the total equity share owned by board member Lars-Håkan Thorell and his family has shrunk to below 10 per cent. 170626 - Emotra - Flagging notification